| Date | Title | Description |
| 13.05.2025 | Finnish startup Tilt Biotherapeutics moves closer to immune-oncology breakthrough with fresh €22.6 million | Helsinki-based TILT Biotherapeutics (Tiltbio), a clinical-stage BioTech company developing intravenously delivered cancer immunotherapies, announced today it has raised €22.6 million in a Series B financing.
The financing was supported by e... |
| 07.05.2025 | Revolutionizing Healthcare: i3's Bold Investment in African Startups | In the heart of Africa, a healthcare revolution is brewing. Investing in Innovation Africa (i3) has taken a bold step, awarding $1.5 million to seven dynamic healthtech startups. This initiative aims to transform pharmacy services across th... |
| 06.05.2025 | Investing in Innovation Africa (i3) Selects 7 Startups for 3rd Cohort | Investing in Innovation Africa (i3), a pan-African initiative dedicated to advancing healthcare access through technology, has announced the selection of seven growth-stage startups for its third cohort.
These companies are pioneering innov... |
| 05.05.2025 | i3 awards $1.5 M to seven African healthtech startups | Investing in Innovation Africa (i3), a pan-African initiative to support African healthtech startups to commercialise and scale their offerings, has announced its 3rd cohort of 7 growth-stage companies working to transform pharmacy services... |
| 05.05.2025 | Europe pledges half a billion euros to lure scientists as Trump battles universities | Previous
Camille Parmesan, ecological researcher, Clarisse Lhoste, President of MSD, Robert Neel Proctor, historian of science at Stanford University, Anne Bouverot, special envoy of the President of the Republic for artificial intelligence... |
| 25.04.2025 | The Evolving Landscape of Oncology: Innovations and Challenges | The world of oncology is a battleground. New weapons are being forged daily, yet the fight against cancer remains daunting. Recent developments from Antengene Corporation and Gilead Sciences highlight both the promise and the pitfalls in th... |
| 24.04.2025 | Antengene to Present Latest Results From Two Clinical Studies at ASCO 2025 | SHANGHAI and HONG KONG, April 24, 2025 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and co... |
| 09.04.2025 | The Robotics Race: Navigating Hype and Reality in China’s Tech Landscape | The landscape of robotics in China is a battleground of ambition and skepticism. As startups like Tars and Spirit AI secure massive funding, doubts loom large. Industry veterans voice concerns about the commercial viability of humanoid robo... |
| 07.04.2025 | Over 250 million people worldwide unaware they have diabetes, according to new research from the International Diabetes Federation (IDF) | New estimates from the IDF Diabetes Atlas highlight the growing diabetes threat, with nearly one in nine adults now living with the condition.
BRUSSELS, April 7, 2025 /PRNewswire/ -- Globally, nearly one in nine adults (589 million) are now... |
| 07.04.2025 | Dreame is bringing its machines into your kitchen—and it’s just getting started | After officially announcing its entry into the major home appliance market, Dreame took center stage at this year’s Appliance & Electronics World Expo (AWE), where it reserved an 800-square-meter booth. Alongside its signature robot vac... |
| 03.04.2025 | The Future of Marketing and Mobility: Navigating Change in Southeast Asia | In the heart of Southeast Asia, two pivotal events are shaping the landscape of business and technology. The MMA CEO & CMO Summit 2025 in Vietnam and Grab's financial turnaround signal a new era for marketing and mobility. These develop... |
| 02.04.2025 | MMA CEO-CMO Summit 2025: Why Vietnam's Top Leaders Can't Miss This Exclusive Gathering | HO CHI MINH CITY, Vietnam, April 2, 2025 /PRNewswire/ -- Returning for its 8th edition, the MMA CEO & CMO Summit 2025 will provide a unique platform to address the evolving challenges and seize emerging opportunities in the marketing se... |
| 26.03.2025 | Singapore's Best Workplaces in Healthcare & Biopharma™ 2025 Announced, Showcasing Insights from Nearly 10,000 Employees | SINGAPORE, March 26, 2025 /PRNewswire/ -- Great Place To Work®, the global authority on workplace culture, has officially announced Singapore's Best Workplaces in Healthcare & Biopharma™ 2025 list, celebrating 10 pioneering healthcare a... |
| 21.03.2025 | Antengene Announces 2024 Full-Year Financial Results, Proprietary Programs Advancing to Pivotal Trials with Accelerating Multi-market Revenue Ramp Up | SHANGHAI and HONG KONG, March 21, 2025 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK) today announced its full-year results for the period ending December 31, 2024, along with several significant milest... |
| 10.03.2025 | Kelun-Biotech's TROP2 ADC Sacituzumab Tirumotecan (sac-TMT) Approved for Marketing in Second Indication by NMPA for EGFRm NSCLC | CHENGDU, China, March 10, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") announced that the Company's trophoblast cell-surface antigen 2 (TROP2)-directed antibody-drug conjugate (ADC) sacitu... |
| 06.03.2025 | To accelerate healthcare market and AI in Southeast Asia, Thailand’s HD HD raised $7.8 M Series A funding | Merck Sharp & Dohme (MSD), a healthcare company based in the United States, participated in a Series A-1 strategic extension round that closed Thursday, bringing HD’s total Series A funding to $7.8 million. HD is a healthcare and surger... |
| 03.03.2025 | Hallvarsson & Halvarsson Strengthens Its Life Science Offering – Recruits Senior Executive from the Pharmaceutical Industry | Hallvarsson & Halvarsson Strengthens Its Life Science Offering – Recruits Senior Executive from the Pharmaceutical Industry
Mon, Mar 03, 2025 14:05 CET Report this content
Jakob Tellgren, most recently Head of Northern Europe and the Ba... |
| 14.02.2025 | Deals in brief: Finmo’s Series A round hits oversubscription, Giftaway and HD raise fresh capital, latest China deals, and more | Finmo raises Series A funding to expand treasury management platform
Finmo, a treasury operating system provider, has raised USD 18.5 million in an oversubscribed Series A funding round, bringing its total funding to USD 27 million. The rou... |
| 12.02.2025 | Navigating the Storm: The Future of U.S. Aid and African Health Initiatives | The landscape of U.S. foreign aid is shifting. Recent developments have sent ripples through the global health sector, particularly in Africa. The Investing in Innovation Africa (i3) initiative is adapting to these changes. It’s a tale of r... |
| 10.02.2025 | After receiving ‘stop-work’ directive from US Aid, Pan-African e-health initiative i3 refocuses on growth-stage startups | The third cohort of Investing in Innovation Africa (i3), a pan-African initiative for startups creating the healthcare supply chains of the future, has undergone a significant shift in selection, giving priority to immediate support for fiv... |
| 10.02.2025 | Investing in Innovation Africa (i3) Announces Third Call for Applications to Empower Healthtech Startups | Investing in Innovation Africa (i3), a pan-African initiative dedicated to supporting health-tech startups has opened applications for its third cohort. The program aims to accelerate the growth and impact of African-led ventures that lever... |
| 03.02.2025 | To assist African startups in healthcare supply chains, i3 announced its third call for applications | Leading innovators are being invited to join the third cohort of Investing in Innovation Africa (i3), a pan-African initiative for startups creating the healthcare supply chains of the future.
With funding from the Bill & Melinda Gates ... |
| 03.02.2025 | African startups in healthcare supply chains can now apply for i3’s third call for applications | i3, a pan-African program for startup companies creating healthcare supply chains of the future, is seeking top innovators to join its third cohort.
With funding from the Bill & Melinda Gates Foundation and support from MSD, Cencora, th... |
| 27.01.2025 | i3 Calls for Applicants to 3rd Cohort for Program Enabling African Healthtech Innovators | Share this:
Click to share on Facebook (Opens in new window)Click to share on WhatsApp (Opens in new window)Click to share on Twitter (Opens in new window)Click to share on LinkedIn (Opens in new window)Click to email a link to a friend (Op... |
| 25.01.2025 | Andhra Pradesh's Bold Bid for Swiss Investment: A New Economic Horizon | Andhra Pradesh is casting its net wide. The state is on a mission to attract Swiss investments in research and development (R&D) and manufacturing. This is not just a call for funds; it’s a strategic move to reshape its economic landsca... |
| 24.01.2025 | Nuevocor Welcomes Andreas Wallnöfer as Chairman of the Board of Directors | SINGAPORE and PHILADELPHIA, Jan. 24, 2025 /PRNewswire/ -- Nuevocor, an IND-stage biotechnology company dedicated to developing functional cures to treat cardiomyopathies with aberrant mechanobiology, today announces the appointment of Dr. A... |
| 15.01.2025 | The Pulse of Workplace Excellence: A Deep Dive into the Best Places to Work for 2024 | In the ever-evolving landscape of employment, the quest for the best workplace is akin to searching for a hidden gem. The Best Places to Work rankings for 2024 have emerged, shining a spotlight on organizations that not only excel in their ... |
| 14.01.2025 | The world’s 30 Best Places to Work for 2024 revealed | NEW YORK, USA – Media OutReach Newswire – 14 January 2025 – The highly anticipated Best Places to Work World Rankings for 2024 have been revealed, showcasing 30 leading organizations from various industries and regions that have demonstrate... |
| 07.01.2025 | Top 25 Best Places to Work in Europe for 2024 revealed | LONDON, UNITED KINGDOM – Media OutReach Newswire – 7 January 2025 – The Best Places to Work organization is proud to announce the Top 25 Best Places to Work in Europe for 2024, recognizing the most outstanding employers who have demonstrate... |
| 06.01.2025 | 150 new jobs as MSD agrees deal for WuXi Vaccines' Dundalk facility | MSD Ireland has agreed to acquire the WuXi Vaccines manufacturing facility in Dundalk, Co Louth for €500m.
The deal will increase the size of MSD's footprint in Ireland to eight locations, and the company plans to add 150 jobs at the 15,520... |
| 11.12.2024 | Oriola renews operating model and management team to accelerate strategy execution | Oriola renews operating model and management team to accelerate strategy execution
Wed, Dec 11, 2024 08:15 CET Report this content
Oriola Corporation Stock Exchange Release 11 December 2024 at 9:15 a.m. EET Oriola renews operating model and... |
| 09.12.2024 | BRIDGING CLINICAL RESEARCH AND CLINICAL CARE WITH AI-AIDING PATHOLOGISTS TOOL | SINGAPORE, Dec. 9, 2024 /PRNewswire/ -- A newly published collaborative study[1] in the Journal of Hepatology, featuring HistoIndex – a global leader in stain-free digital pathology solutions for managing fibrotic diseases – alongside Merck... |
| 30.10.2024 | Teijin and Hilleman Laboratories to Expand Business in Asia-Pacific via Strategic Partnership to Promote CDMO Services in Cell and Gene Therapy | SINGAPORE, Oct. 30, 2024 /PRNewswire/ -- Teijin Limited and Hilleman Laboratories, a biotechnology company based in Singapore, announced today the signing of a Memorandum of Understanding, for the establishment of a strategic international ... |
| 15.10.2024 | PharmAbcine Announces Safety Approval for 4mg Single-dose Cohort in Phase 1 Clinical Trial of PMC-403 for Neovascular Age-related Macular Degeneration | Safety Review Committee (SRC) approves single ascending dose 4mg cohort in Phase 1 trial of PMC-403, preparing for multiple ascending dose 4 mg cohort.
PMC-403 is being explored in broader therapeutic areas, including rare vascular disease ... |
| 09.10.2024 | Commvault launches cyber resilience platform on AWS | Commvault has announced the availability of its Commvault Cloud cyber resilience platform on Amazon Web Services (AWS), including features such as Cleanroom Recovery, Commvault SaaS Offerings, Air Gap Protect, and Cloud Rewind.
The Commvaul... |
| 05.10.2024 | The Next Frontier in Cancer Treatment: ABL Bio and TiumBio Forge Ahead with Innovative Therapies | In the relentless battle against cancer, two South Korean biopharmaceutical companies, ABL Bio and TiumBio, are making significant strides. Their recent announcements signal a promising future for patients grappling with advanced solid tumo... |
| 04.10.2024 | ABL Bio Announces Clinical Collaboration to Evaluate ABL103 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Solid Tumors | - MSD will supply KEYTRUDA to be evaluated in combination with ABL Bio's ABL103 in a Phase 1b/2 clinical trial
SEONGNAM, South Korea, Oct. 4, 2024 /PRNewswire/ -- ABL Bio (CEO Sang Hoon Lee), a company specializing in bispecific antibodies,... |
| 09.09.2024 | Three Study Results Abstracts From Kelun-Biotech's TROP2-ADC SKB264 (sac-TMT) At 2024 ESMO Released Today | CHENGDU, China, Sept. 9, 2024 /PRNewswire/ -- The European Society for Medical Oncology (ESMO) Congress 2024 will be held in Barcelona, Spain from September 13 to 17, 2024. Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd（"Kelun-Biotec... |
| 23.08.2024 | Antengene Announces 2024 Interim Financial Results, Highlights Progress in R&D and Commercialization | SHANGHAI and HONG KONG, Aug. 23, 2024 /PRNewswire/ -- Antengene Corporation (6996.HK) today announced its interim results for the period ending June 30, 2024, along with several significant milestones achieved in recent months.
Dr. Jay Mei,... |
| 15.08.2024 | Clinical advancements at ImmunOs Therapeutics and Noema Pharma |
ImmunOs Therapeutics AG, a biopharmaceutical company using its HLA-based technology platform to develop first-in-class and innovative therapeutics for the treatment of cancer and autoimmune diseases, has expanded its ongoing Phase I clinic... |
| 19.07.2024 | BioStock: BioInvent and MSD to evaluate new metastatic melanoma treatment | BioStock: BioInvent and MSD to evaluate new metastatic melanoma treatment
Fri, Jul 19, 2024 11:00 CET Report this content
BioInvent, known for its innovative cancer immunotherapies, is expanding its partnership with MSD to test BI-1607 in c... |
| 21.06.2024 | Ascentage Pharma Announces Closing of US$75 Million Equity Investment by Takeda | ROCKVILLE, Md. and SUZHOU, China, June 21, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced ... |
| 18.06.2024 | Live from EHA 2024 | Ascentage Pharma Releases Updated Data of Lisaftoclax in Patients with R/R MM and AL Amyloidosis Highlighting Marked Improvement in ORR | SUZHOU, China and ROCKVILLE, Md., June 18, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced ... |
| 11.06.2024 | Biotech startups make clinical progress |
The U.S. Food and Drug Administration (FDA) has accepted the Investigational New Drug (IND) application from Anaveon to conduct a Phase I/II study evaluating the safety and clinical activity of their drug candidate ANV600. As the company’s... |
| 11.06.2024 | Global Registrational Phase III Study of Olverembatinib for the Treatment of Patients with SDH-Deficient GIST Approved by the China CDE | SUZHOU, China, and ROCKVILLE, Md., June 11, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced... |
| 05.06.2024 | Live from ASCO 2024 | Ascentage Pharma Releases Updated Data Showing Promising Efficacy and Safety of Lisaftoclax in Patients with WM | SUZHOU, China, and ROCKVILLE, Md., June 5, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced ... |
| 05.06.2024 | Live from ASCO 2024 | Oral Report Released Latest Data of Olverembatinib in SDH-Deficient GIST, Including a CBR of 92.3% | SUZHOU, China and ROCKVILLE, Md., June 5, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced t... |
| 04.06.2024 | Live from ASCO 2024 | Updated Data of Bcl-2 Inhibitor Lisaftoclax Combined with Azacitidine in Patients with AML Demonstrate Promising Efficacy and Manageable Safety | SUZHOU, China and ROCKVILLE, Md., June 4, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced t... |
| 04.06.2024 | New test detects more cases of cervical cancer | New test detects more cases of cervical cancer
Tue, Jun 04, 2024 11:00 CET Report this content
Researchers at Karolinska Institutet in Sweden and the University of Innsbruck in Austria have developed a simpler and more effective screening m... |
| 31.05.2024 | Deals in brief: Lenovo signs USD 2 billion agreement with PIF’s Alat, HSBC leads Series A investment in Marketnode, eight China and India deals, and more | NewsDeals in brief: Nvidia co-launches AI accelerator in Singapore, Merck acquires EyeBio, Amazon considering buyout of MX Player, and more
Written by KrASIA Writers Nvidia, Lhoopa, Merck, and more led yesterday’s headlines: Nvidia has part... |
| 31.05.2024 | Aurobindo arm TheraNym inks pact with MSD for biologics manufacturing | - |
| 16.05.2024 | EHA 2024 | Results from Five Studies of Ascentage Pharma's Key Drug Candidates Selected for Presentations at 2024 European Hematology Association Hybrid Congress | SUZHOU, China and ROCKVILLE, Md., May 16, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced t... |
| 13.05.2024 | Maria Alfaiate appointed new Executive Vice President Commercial and Corporate Strategy at Lundbeck | Maria Alfaiate appointed new Executive Vice President Commercial and Corporate Strategy at Lundbeck
Mon, May 13, 2024 09:00 CET Report this content
H. Lundbeck A/S (Lundbeck) today announced the appointment of Maria Alfaiate to the newly es... |
| 13.05.2024 | Astellas Showcases Scientific Advancements Across its Oncology Portfolio at 2024 ASCO Annual Meeting | 16 abstracts feature new data and post-hoc analyses of pivotal trials across several types of hard-to-treat cancers
TOKYO, May 13, 2024 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas")... |
| 25.04.2024 | ASCO 2024 | Ascentage Pharma to Present Four Studies, Including an Oral Report Featuring the Latest Data of Olverembatinib in SDH-Deficient GIST | SUZHOU, China and ROCKVILLE, Md., April 25, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced... |
| 24.04.2024 | Hanmi Enters into Clinical Trial Collaboration and Supply Agreement with MSD to Evaluate BH3120 in Combination with KEYTRUDA® (pembrolizumab) | Hanmi Pharmaceutical announces Clinical Trial Collaboration with MSD to evaluate 'BH3120' in combination with KEYTRUDA in phase 1 clinical trial in patients with progressive or metastatic solid tumors
SEOUL, South Korea, April 24, 2024 /PRN... |
| 08.04.2024 | AACR 2024 | Ascentage Pharma Presents Results from Three Studies at 2024 American Association of Cancer Research Annual Meeting | ROCKVILLE, Md. and SUZHOU, China, April 8, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, age-related diseases, and chronic hepatitis B (CHB), announced ... |
| 22.03.2024 | Antengene Announces Full Year 2023 Financial Results, Highlights Clinical Progress Across First-in-Class, Best-in-Class Pipeline | Promising clinical activities and efficacies during dose escalations for four lead global rights programs targeting CD24, Claudin 18.2, CD73, and PD-L1/4-1BB
Positive, differentiated cervical cancer data advancing mTORC1/2 inhibitor on regi... |
| 15.03.2024 | IAB HK Spring Dinner & Digital Awards Gala 2023: Celebrate digital brilliance with 350 marketers | HSBC is crowned Best Digital Campaign of the Year
HONG KONG, March 15, 2024 /PRNewswire/ -- As one of the most active advertising and digital marketing associations in Hong Kong, IAB Hong Kong (IAB HK) successfully held its Spring Dinner &a... |
| 06.03.2024 | AACR 2024 | Ascentage Pharma to Present Three Preclinical Studies at 2024 American Association of Cancer Research Annual Meeting | ROCKVILLE, Md. and SUZHOU, China, March 6, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, age-related diseases, and chronic hepatitis B (CHB), announced ... |
| 21.06.2023 | The multibillion-dollar burden: managing the costs of covid-19 | Economist Impact's The multibillion-dollar burden managing the costs of covid-19 | June 28th 2023, 11:30 am SGT
Join 150 policy and business leaders and explore ways to manage the indirect costs to businesses of endemic covid-19. HONG KONG,... |
| 09.01.2023 | Nouscom and MSD sign a clinical trial and supply agreement | |
| 04.07.2022 | Southbridge A&I, Salient Advisory and SCIDaR launch I3, a $7 million program for HealthTech in Africa sponsored by the Gates Foundation and operated in Southern Africa by Startupbootcamp Afritech | The pan-African “Investing in Innovation” program will provide 30 HealthTech startups per year, operating in Africa, with access to: 1) a systematic grant of $50,000 2) market and government access events across the continent 3) a connectio... |
